Literature DB >> 12196122

The contrasting IgG-binding interactions of human and herpes simplex virus Fc receptors.

K L Armour1, A Atherton, L M Williamson, M R Clark.   

Abstract

A virally encoded, high-affinity Fc receptor (FcR) is found on herpes simplex virus type 1 (HSV-1) particles and infected cells where its binding of non-immune IgG protects cells from host-mediated lysis. Whilst mutation or aglycosylation of the IgG CH2 domain reduced binding to human FcR, the interaction with HSV-1 FcR was not affected. However, the HSV-1 FcR, unlike human FcR, discriminates between human IgG1 allotypes, being sensitive to changes at positions 214 (CH1) and 356/358 (CH3), away from its proposed binding site at the CH2-CH3 interface. The biological consequences are not known but this is the first evidence of a major functional difference between IgG1 allotypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196122     DOI: 10.1042/bst0300495

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration.

Authors:  Jin-Dong Ding; Lincoln V Johnson; Rolf Herrmann; Sina Farsiu; Stephanie G Smith; Marybeth Groelle; Brian E Mace; Patrick Sullivan; Jeffrey A Jamison; Una Kelly; Ons Harrabi; Sangeetha Subbarao Bollini; Jeanette Dilley; Dione Kobayashi; Bing Kuang; Wenlin Li; Jaume Pons; John C Lin; Catherine Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

2.  Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Chin-Fun Chu; Michael G Meador; Christal G Young; Jane E Strasser; Nigel Bourne; Gregg N Milligan
Journal:  J Reprod Immunol       Date:  2007-10-24       Impact factor: 4.054

3.  Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging.

Authors:  Elizabeth R Sprague; Chu Wang; David Baker; Pamela J Bjorkman
Journal:  PLoS Biol       Date:  2006-05-02       Impact factor: 8.029

4.  Targeting the myeloid checkpoint receptor SIRPα potentiates innate and adaptive immune responses to promote anti-tumor activity.

Authors:  Tracy C Kuo; Amy Chen; Ons Harrabi; Jonathan T Sockolosky; Anli Zhang; Emma Sangalang; Laura V Doyle; Steven E Kauder; Danielle Fontaine; Sangeetha Bollini; Bora Han; Yang-Xin Fu; Janet Sim; Jaume Pons; Hong I Wan
Journal:  J Hematol Oncol       Date:  2020-11-30       Impact factor: 17.388

Review 5.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11

6.  Herpesviral Fcgamma receptors: culprits attenuating antiviral IgG?

Authors:  Matthias Budt; Henrike Reinhard; Arndt Bigl; Hartmut Hengel
Journal:  Int Immunopharmacol       Date:  2004-09       Impact factor: 4.932

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.